Company ProfilePremium

NeuRizer Ltd.

Company Profile Analysis

Ticker: NRZ.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
NeuRizer Ltd. - Company showcase

NeuRizer Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

NeuRizer Ltd. Overview

NeuRizer is a pre-revenue South Australian project developer. Its sole flagship asset is the NeuRizer Urea Project (NRUP) at Leigh Creek, a proposed vertically integrated fertiliser complex. The project would gasify unmined coal underground (in-situ gasification, ISG, also called underground coal gasification, UCG) to produce syngas, power and CO2 on site, then convert them into granular urea. Initial capacity is planned at 1 Mtpa, with potential expansion to 2 Mtpa [S23]. The company proved the gasification process in a 2018–19 pre-commercial demonstration. Since 2023, however, the commercial project has been held up by a federal EPBC Act assessment (the "water trigger"). That delay, together with a liquidity crisis, a debt to its EPC partner and a prolonged ASX suspension, defines the company's position today. In March 2026 NeuRizer monetised its intellectual property and demonstration plant through agreements with India's Reliance Industries worth up to A$13.0M [S11]. Equity value is now an option on two outcomes: EPBC approval and the funding of a multi-billion-dollar plant.


Company's own description. NeuRizer's ASX materials describe it as the company responsible for progressing the NeuRizer Urea Project [S30]. Its stated aim is to be Australia's leading manufacturer of urea, the building block of crop production [S20]. NRZ emphasises that the NRUP would be the only fully integrated urea facility in Australia, with gas, power and CO2 produced on site [S24]. That integration would let the company control both supply and price of the major input costs [S30]. Until 2024, the company also marketed itself as a certified carbon-neutral organisation (Climate Active) and described the NRUP as carbon neutral from first production [S30], [S24]. In 2024 NeuRizer told investors to disregard previous "net zero carbon" claims in its ASX announcements, after the Conservation Council of South Australia raised the matter with ASIC [S15].

Business model (intended). The planned value chain has five stages:

  1. Gasify coal in situ at Leigh Creek to produce syngas.

  2. Use the syngas to generate power and process gas.

  3. Produce ammonia.

  4. React the ammonia with captured CO2 to make urea melt.

  5. Granulate the melt for sale.

Urea technology is licensed from Stamicarbon (LAUNCH MELT Flash Design with pool reactor; LAUNCH FINISH Granulation) [S24]. The company has claimed that, because it would self-supply three of the four major cost inputs (gas, CO2 and nitrogen), it could produce urea at a cash cost of about A$109/t. It projected a long-run average retail price of A$800–900/t [S25]. These are company and consultant projections, not demonstrated outcomes.

Revenue model. Historically nil operating revenue (product revenue A$0 FY2020–FY2024 [S18]). From FY2026 the company is earning licensing and asset-sale income from Reliance Industries:

  • an IP technology-transfer licence worth A$10.3M;

  • a plant and equipment sale worth A$2.7M;

  • both paid through up-front, milestone and monthly payments over about 15 months [S11].

The current revenue mix is therefore 100% licensing and asset disposal. The intended long-run mix is ~100% product (urea), with possible by-products such as power and gas.

Value chain position. If built, the company would sit upstream as an integrated primary nitrogen fertiliser producer, covering feedstock, ammonia synthesis and urea production. Customers would be distributors and traders. A binding long-term offtake was signed with Daelim's trading arm (DL Trading) in 2H 2022 [S3].

Customer types and end-markets. Customers would be Australian broadacre grain growers (via distributors) and export agriculture markets [S15]. NRZ claims a 1 Mtpa plant would meet about one-third of Australia's annual urea demand for grain production [S15].

Independent characterisation. NeuRizer is best understood as a distressed, single-asset, regulatory-option development company. It currently has no production, negative working capital and audited accounts more than two years old. Its main 2026 cash source is non-recurring monetisation of legacy IP and equipment. Its technology choice, UCG, carries severe reputational baggage in Australia because of the Linc Energy Chinchilla contamination case. The executive chairman was formerly an environment and government-relations manager at Linc, although he was not charged [S15].

Strategy

Stated strategic themes (company materials, 2022–2026):

  1. Become Australia's first, and only fully integrated, domestic urea producer, supporting national fertiliser sovereignty [S23], [S24].

  2. Lowest-cost producer via on-site gas, power and CO2 [S25].

  3. Low-carbon or decarbonisation pathway with CCS (carbon-neutral claims since withdrawn) [S15], [S25].

  4. Survive the regulatory process: preserve the tenements, satisfy SA licence conditions and complete the federal EIS [S10], [S15].

  5. Monetise non-core IP and assets internationally (Reliance) to fund corporate costs without dilution [S11].

Medium-term targets and guidance. No formal financial guidance is given. In April 2026 management said the Reliance funding would cover about 18 months of corporate costs [S15]. The Executive Chairman expected federal approvals to take roughly another year [S15]. Earlier timelines are void: 2022 guidance targeted urea deliveries by March/April 2025 [S25] and full production by 2025 [S26].

Products & Services

NeuRizer has no commercial products in production. Its catalogue consists of a development project, a licensable technology package and legacy assets.

Product Portfolio

OfferingDescriptionKey specifications / capabilitiesTarget customerStatus / yearPricing modelSource

NeuRizer Urea Project (NRUP), full scale

Integrated ISG-to-urea complex at Leigh Creek

1 Mtpa urea initial, potential 2 Mtpa; claimed cash cost ~A$109/t; capex framed at A$2.6B (2022)

Australian distributors and growers; export markets

Pre-FID; under EPBC assessment; no construction

Planned commodity sales; claimed long-run retail price A$800–900/t

[S23], [S25]

NRUP Stage 1

Commercial demonstration: several ISG gasifiers feeding a small power station

Builds on the 2018–19 PCD; declared Major Project in SA

Regulators, financiers (de-risking step)

EIS response submitted to DCCEEW, Q4 FY2026

—

[S10]

Granular urea (planned product)

Nitrogen fertiliser, 46% N standard grade (industry standard; NRZ grade spec not disclosed)

Stamicarbon LAUNCH MELT (pool reactor) and LAUNCH FINISH granulation

Grain growers

Not produced

Offtake with DL Trading (2H 2022)

[S3], [S24]

ISG/UCG intellectual property package

NeuRizer's gasification know-how, procedures and data from the PCD

Perpetual, irrevocable licence; exclusive for India per secondary reporting

Reliance Industries Ltd

LOA1 signed 13 Mar 2026

A$10.3M via up-front, milestone and monthly payments over ~15 months

[S11], [S27]

Demonstration plant and equipment

Gas flare, piping, valves, tanks, thermal oxidiser, gas spectrometer, etc.

To be dismantled, containerised and rebuilt in India

Reliance Industries Ltd

LOA2 signed 13 Mar 2026; shipping planned Q1 FY2027

A$2.7M

[S10], [S11]

Technical services (draft)

Technical Services Agreement and Master Contract with Reliance

Long-term relationship framework

Reliance Industries Ltd

Draft (not executed as at Mar 2026)

—

[S12]

Siemens power generators (4 units)

Gas-fired generators from the PCD

Sold for A$2.0M and leased back for 2 years with buy-back option

PremiAir Hire (buyer and lessor)

Apr 2024

Sale and leaseback

[S6]

Hydrogen (China) concept

Announcement on producing hydrogen in China

——

Jun 2023 announcement; no subsequent progress verified

—

[S22]

Tenement portfolio

PEL 650, PPL 269, AAL 292, PRL 247, GSEL 662, PELA 647 (all 100%)

Leigh Creek coalfield; gas storage potential

Internal (feedstock)

Granted 2014–2020

—

[S10]

“—” = not publicly disclosed.

Financial Narrative

Data basis. The five most recent audited fiscal years are FY2020–FY2024. FY2025 audited statements have not been lodged [S10]. Income statement and cash-flow lines come from TipRanks [S18], which is derived from company annual reports. Balance-sheet lines for FY2021–FY2023 come from InvestSMART/Morningstar [S19]. Where aggregators differ, both figures are shown.

Income statement

Sources: [S18]. EPS is computed as net income divided by weighted average shares; aggregator-reported EPS rounds to A$-0.01/-0.02.

Interim data points.

  • 1H FY2023 (to 31 Dec 2022): loss A$9.36M versus A$8.07M in 1H FY2022 [S3].

  • 1H FY2024 (to 31 Dec 2023): consolidated operating loss A$0.80M; NRUP expenditure capitalised as exploration A$0.72M [S4].

Margins. Gross, operating, EBITDA and net margins are not meaningful because revenue is nil in every year FY2020–FY2024. Revenue CAGR is not meaningful for the same reason.

Commentary. Losses scaled with front-end engineering and design (FEED) and pre-development work, peaking at A$20.4M in FY2022. The FY2022 total included A$7.95M of non-operating charges (finance and other costs). The FY2024 collapse in operating expenses (A$2.61M versus A$13.54M) reflects forced cost-cutting:

  • the MD redundancy;

  • a halt to EPC engineering after the EPBC referral;

  • capitalisation of residual project spend.

The inflection point is clearly CY2023, when the federal water-trigger referral removed the near-term construction path.

Balance sheet

Source: [S19].

The capitalised exploration and evaluation asset was A$93.47M in the 31 Dec 2022 interim balance sheet, against a comparative of A$50.11M [S3]. The comparative column date is shown as reported; aggregator non-current asset totals differ, so this is flagged as a possible classification difference.

Cash at period end (A$M)

Source: [S18].

Debt. The principal liability since FY2023 has been amounts owed to DL E&C under the NRUP engineering arrangements. Interest accrues on this debt, and DL can call it at any time [S7]. The exact current balance is not publicly disclosed in sources reviewed. FY2026 Appendix 5Bs show repayments of borrowings of A$1.141M for the year, including A$0.763M in the June quarter [S10]. Short- versus long-term debt split and net debt/EBITDA are not publicly disclosed (and EBITDA is negative).

Commentary. The balance sheet changed character between FY2021 and FY2023:

  • Working capital swung from +A$19.5M to -A$53.6M as engineering payables to DL E&C accumulated and cash was spent on capitalised FEED.

  • Total assets grew because spending was capitalised, not because of revenue-generating capacity.

  • The near-total collapse in current assets by FY2023 (A$1.43M) underpinned ASX's October 2024 finding of an inadequate financial condition [S1].

Cash flow

Sources: [S18]; InvestSMART agrees on operating cash flow (-9.05 / -10.23 / -4.61) and approximately on investing (-16 / -28 / -3) [S19]. The two FCF rows differ because the aggregator's definition is not disclosed; the computed proxy is recommended.

FY2026 unaudited cash flow (Appendix 5B, 12 months to 30 Jun 2026; A$M) [S10]

These internal inconsistencies reinforce concerns about the quality of financial reporting.

Ratios

Computed from [S18], [S19].

  • ROIC, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are not meaningful because revenue and EBITDA are negative or nil.

  • InvestSMART reports net interest cover of -1.88 (FY2021), -1.57 (FY2022) and -3.71 (FY2023) [S19].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Results by Segment

MetricFY2022FY2023FY2024

Segment revenue NRUP Development (AUD Mn)

000

Segment operating income NRUP Development (AUD Mn)

-12.45-12.60-2.80

Segment pre-tax income NRUP Development (AUD Mn)

-20.40-16.26-5.60

Share of group revenue (%)

000

Income Statement and Share Count (M)

MetricFY2020FY2021FY2022FY2023FY2024

Revenue (AUD Mn)

00000

Gross profit (AUD Mn)

-0.08-0.18-0.16-0.05-0.03

Operating expenses (AUD Mn)

7.008.9112.2913.542.61

Operating income (AUD Mn)

-7.03-8.86-12.45-12.60-2.80

EBITDA (AUD Mn)

-6.92-8.68-12.29-12.55-4.48

Other income/expense (AUD Mn)

-0.13-4.72-7.95-3.66-2.81

Pre-tax income (AUD Mn)

-7.16-13.57-20.40-16.26-5.60

Net income (AUD Mn)

-7.16-13.57-20.40-16.26-5.60

Weighted avg shares (M)

567.41658.34823.821,0301,430

EPS basic computed (A$ cents)

-1.26-2.06-2.48-1.58-0.39

EPS diluted computed (A$ cents)

-1.26-2.06-2.48-1.58-0.39

Dividends per share (A$ cents)

00000

Balance Sheet

MetricFY2021FY2022FY2023

Total current assets (AUD Mn)

23.2716.071.43

Total non-current assets (AUD Mn)

31.975.5127.2

Total assets (AUD Mn)

55.291.6128.7

Total current liabilities (AUD Mn)

3.7734.2755.07

Total non-current liabilities (AUD Mn)

0.110.850.84

Total liabilities (AUD Mn)

3.8835.1255.91

Shareholders equity (AUD Mn)

51.356.572.8

Working capital computed (AUD Mn)

19.50-18.20-53.64

Goodwill and intangibles (AUD Mn)

000

Key Financials

MetricFY2020FY2021FY2022FY2023FY2024

Cash and equivalents (AUD Mn)

6.8122.810.441.210.57

Cash Flow

MetricFY2020FY2021FY2022FY2023FY2024

Operating cash flow (AUD Mn)

0.90-4.61-10.23-9.05-3.56

Investing cash flow (AUD Mn)

-2.76-3.14-27.63-16.110.83

Financing cash flow (AUD Mn)

6.3823.7515.4925.922.09

FCF proxy OCF plus investing (AUD Mn)

-1.86-7.75-37.86-25.16-2.73

FCF as reported by TipRanks (AUD Mn)

-1.86-8.27-16.47-34.32-6.09

Dividends paid (AUD Mn)

00000

Buybacks (AUD Mn)

00000

Financial Analysis

ItemQ4 FY2026FY2026 YTD

Receipts from customers

4.1004.250

Staff costs

-0.244-0.871

Administration and corporate

-1.597-4.712

Net operating cash flow

2.259-1.330

Exploration and evaluation (investing)

-0.184-0.425

Repayment of borrowings

-0.763-1.141

Cash at end of period (item 4.6)

1.312—

Bank balance (item 5.1)

1.386—

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023

ROE computed (%)

-26.5-36.1-22.3

ROA computed (%)

-24.6-22.3-12.6

Current ratio computed (x)

6.170.470.03

Total liabilities to equity computed (x)

0.080.620.77

Geographic Revenue

MetricFY2022FY2023FY2024

Revenue Australia (AUD Mn)

000

Revenue rest of world (AUD Mn)

000

Capital Markets Data (AUD)

MetricFY2020FY2021FY2022FY2023FY2024

52-week high (AUD)

0.2650.230.1950.0610.013

52-week low (AUD)

0.0640.100.050.0020.001

Analyst Conclusions

Management guidance:

  • Reliance payments are expected to fund about 18 months of corporate costs, the EIS process and feasibility tendering [S15].

  • Invoices of A$3.5M+ were due to be paid in Q1 FY2027 [S10].

  • The company intends to apply for reinstatement once the FY2025, 1H FY2026 and FY2026 accounts are lodged [S10].

  • No production or financial guidance has been given. No consensus estimates exist.

Bull case:

  1. Regulatory breakthrough in a supply crisis. The EIS response is lodged [S10], federal reforms promise faster decisions [S15], and urea at about A$1,500/t [S15] raises the political value of a domestic 1 Mtpa source.

  2. Self-funded runway. Up to A$13.0M of Reliance income [S11] removes the need for highly dilutive raises at A$0.001, and the June quarter already showed a A$2.26M operating inflow [S10].

  3. Recurring Reliance economics. Execution of the draft Technical Services Agreement and Master Contract [S12] could turn a one-off sale into a services revenue line and validate ISG internationally.

Bear case:

  1. Balance sheet impairs equity. Working capital was A$-53.6M in FY2023 [S19] and the DL E&C debt is callable [S7]. Even with Reliance cash, equity may hold little residual value. ASX has already formally found the financial condition inadequate [S1].

  2. Approval risk is binary and adverse. UCG faces the Linc Energy precedent and greenwashing scrutiny [S15]. A rejection or onerous conditions would strand the A$2.6B project [S23].

  3. Governance and reporting deficits. Accounts are more than a year overdue, quarterly reports are internally inconsistent [S10], [S17], and there is no chair/CEO separation [S5]. Together with sustained suspension, these raise delisting risk.

Key catalysts and monitorables (next 12 months):

  • Lodgement and EY audit opinion on the FY2025 accounts (watch for a going-concern emphasis or qualification).

  • 1H FY2026 and FY2026 accounts; any ASX reinstatement decision.

  • DCCEEW progress on the Stage 1 EIS and any subsequent public comment period.

  • Receipt of Reliance milestone payments and shipment of the plant to India.

  • Execution of the Reliance Technical Services Agreement and Master Contract.

  • Status of the DL E&C debt and any restructuring.

  • AGM and any board changes.

  • Urea price normalisation after the Hormuz disruption.

Analyst verdict. NeuRizer is not an operating company to be valued on earnings. It is a distressed option on a single regulatory decision, and its shareholders sit behind significant creditor claims. The industrial logic of the NRUP has genuine appeal: integrated feedstock, a credible licensor in Stamicarbon, a proven 2018–19 demonstration and, in 2026, a national urea supply shock that turns "fertiliser sovereignty" from a slogan into a policy priority. The Reliance agreements are the most constructive development in three years. They show that a large industrial group will pay real money for NeuRizer's know-how, and they buy time without issuing shares at a tenth of a cent.

Yet the evidence weighs against equity holders.

Liabilities: the last audited balance sheets show the liabilities that triggered ASX's 2024 finding of inadequate financial condition, and the DL E&C claim remains callable.

Reporting: the FY2025 accounts are more than a year late, and the latest quarterly reports contain arithmetic inconsistencies.

Governance: a combined executive chair role concentrates decision-making at precisely the moment external oversight is most needed.

Technology: UCG carries some of the heaviest social-licence baggage of any Australian resource process, and federal regulators have signalled no special treatment.

Strategic leverage: licensing the IP to Reliance monetises the company's main intangible today but reduces its leverage tomorrow.

Even a favourable EPBC outcome only opens the next and harder gate: financing a multi-billion-dollar plant for a micro-cap with no market access, thin governance resources and a contested technology.

The appropriate stance is to monitor, not underwrite. The decisive near-term signals are the audit opinion on FY2025, reinstatement to quotation, the size and treatment of the DL debt in the audited accounts, and any DCCEEW decision on Stage 1. Absent clean audited accounts and a federal approval pathway, the equity should be treated as a highly speculative, possibly zero-recovery instrument.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / notesBackgroundSource

Justyn Peters

Executive Chairman (also performs MD duties since 15 Jan 2024)

—

Former General Manager, Environment and Government Relations at Linc Energy (not charged in Linc proceedings; charges against individual executives were dropped)

[S5], [S15]

Jordan Mehrtens

Director

Appointed 12 Feb 2024

—

[S4]

Manyoo Han

Non-Executive Director

——

[S29]

Tony Lawry

Head of Investor and Corporate Relations

Long-serving

—

[S10], [S25]

Phil Staveley

Former Managing Director (earlier CFO)

Joined 2015; role made redundant 15 Jan 2024

—

[S5]

“—” = not publicly disclosed.

Major Shareholders

HolderSharesStake (%)

Citicorp Nominees Pty Ltd

144,777,1866.64

Super 6 Investment Pty Ltd

42,462,0231.95

Hephzibah Pty Ltd (Butt Family Super A/C)

33,725,5011.55

Finclear Services Pty Ltd (Superhero Securities A/C)

28,623,3101.31

Hephzibah Pty Ltd (The Butt Family A/C)

27,218,8101.25

Burton's Holdings (NSW) Pty Ltd

23,263,1581.07

KCL Super Pty Ltd

21,044,7850.96

Rosemount Property Developments Pty Ltd

20,000,0000.92

CNSC1001 Pty Ltd

15,683,3460.72

LRM Holding Company Pty Ltd

15,000,0000.69

Competitive Landscape

Key Competitors

CompetitorSegment overlapPosition vs NRZ

Perdaman Group, Project Ceres (Karratha, WA)

Domestic urea development

~2.3 Mtpa planned; most advanced domestic rival; gas-based

Strike Energy (ASX: STX)

Domestic urea proposal (WA)

—

Dyno Nobel / Incitec Pivot (ASX: DNL/IPL)

Australian nitrogen; former Gibson Island urea

—

CSBP (Wesfarmers)

WA ammonia and nitrogen fertilisers

Incumbent

Yara International

Global urea and nitrogen; Pilbara ammonia

Global major; import competitor

CF Industries

Global nitrogen

Global major

Nutrien

Global nitrogen; Australian ag retail

Global major and channel owner

SABIC Agri-Nutrients / QAFCO / Fertiglobe

Middle East export urea

Lowest-cost gas producers; key import sources (disrupted 2026)

OCI / Koch Fertilizer

Global nitrogen

Global majors

Ergo Exergy / legacy UCG players (e.g., former Linc Energy)

UCG technology

Linc's failure shapes regulatory scepticism

Peer Comparison FY2024

MetricNeuRizerPerdaman Ceres

Revenue

A$0 (FY2024)

Pre-revenue

Growth

n/m

n/m

Operating margin

n/m

n/m

R&D intensity

n/m

n/m

Planned or actual urea capacity

1 Mtpa planned

2.3 Mtpa planned

Recent Developments

Many items in this period are routine compliance releases; no litigation, layoffs or guidance revisions beyond those listed were identified.

Company Snapshot

Adelaide, Australia

Headquarters

SWOT Analysis

Strengths

  • Granted tenure: 100% of PEL 650, PPL 269, AAL 292, PRL 247, GSEL 662 [S10]
  • Proven demonstration: 2018–19 PCD completed with no reported environmental or safety issues per company and state monitoring [S15]
  • Integrated low-cost thesis: Consultant-modelled cash cost A$109/t [S25]
  • Tier-1 technology licensor: Stamicarbon LAUNCH MELT and FINISH [S24]
  • Third-party validation of IP: Reliance pays A$10.3M for an IP licence [S11]
  • State support: Stage 1 declared SA Major Project; legacy mine infrastructure licensed from the state [S10], [S25]

Weaknesses

  • No revenue from operations: Nil revenue FY2020–FY2024 [S18]
  • Insolvency-level working capital: FY2023 working capital A$-53.6M [S19]; ASX LR 12.2 finding [S1]
  • Reporting failures: FY2025 annual report and 1H FY2026 interim overdue [S10]; internal 5B inconsistencies [S10], [S17]
  • Governance concentration: Executive Chairman also acts as MD since Jan 2024 [S5]
  • Creditor dependence: DL E&C can call its debt at any time [S7]
  • Credibility of guidance: 2022 guidance of first urea by March/April 2025 missed [S25]

Opportunities

  • Supply-security crisis: Urea about A$1,500/t versus about A$700/t pre-war [S15]
  • EPBC reform: Government cites 2025 legislation to speed approvals [S15]
  • Reliance relationship: Draft Technical Services Agreement and Master Contract could bring recurring fees [S12]
  • Political advocacy: Federal Member for Grey lobbying the Minister [S15]
  • Gas storage optionality: GSEL 662 held [S10]
  • Phased de-risking: Stage 1 small power station before full urea plant [S10]

Threats

  • EPBC rejection or conditions: Federal assessment ongoing since 2023 referral [S15]
  • Delisting: Long-term suspension under LR 17.5 [S10], [S22]
  • Funding runway: About 18 months of corporate costs from Reliance funds [S15]; 0.63 quarters of funding at 30 Jun 2026 on 5B arithmetic [S10]
  • Social licence: Linc Energy precedent and greenwashing allegations [S15]
  • Competing projects: Perdaman Ceres at 2.3 Mtpa [S26]
  • Loss of IP leverage: Licence weakens NRZ's negotiating position once Reliance replicates the process in India [S27]

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Oct 2024ASX suspends NRZ for late periodic report [S1]Start of the current suspension era
28 Oct 2024FY2024 Annual Report lodged [S9]Last audited annual accounts
29 Oct 2024ASX invokes LR 12.2 (inadequate financial condition) [S1]Suspension now tied to solvency, not just late filing
19 Nov 2024Company indicates expected lifting of suspension [S29]Expectation not realised
22 Jan 2025Private placement A$150k [S29]Micro-funding
29 Jan 2025December 2024 quarterly report [S29]Ongoing compliance
17 Feb 2025Private placement A$200k [S29]Micro-funding
8 Apr 2025Aggregator records sharp price drop [S21]Market pricing of distress
Mid-2025NRZ appears on ASX Long Term Suspended Entities lists [S22]Delisting risk rises
30 Jun 2025FY2025 ends; annual report not lodged by statutory deadline [S10]Reporting breach
Jul–Sep 2025Exclusive discussions with Reliance; monthly consultancy on ISG sites and capability gaps in India [S14]Pivot to IP monetisation
Jul–Sep 2025Groundwater, air and water monitoring and PCD preservation continue [S14]Maintain licence compliance
Oct–Dec 2025Non-binding term sheet with Reliance [S14]Path to LOAs
17 Feb 2026Aggregator records another price-drop date [S21]Continued distress
13 Mar 2026LOA1 (A$10.3M) and LOA2 (A$2.7M) signed with Reliance; plant dismantling starts [S11]Funding lifeline
13 Mar 2026Chairman's letter: short- to medium-term funding resolved, allowing lodgement of overdue reports [S12]Restores going-concern narrative
Mar 2026Strait of Hormuz closure amid Middle East war disrupts urea supply [S15]Sharpens Australian supply-security case
31 Mar 2026Overdue Q1 and Q2 FY2026 quarterlies lodged [S14]Compliance catch-up
Apr 2026Reliance payments begin [S13]First material receipts
16–17 Apr 2026InDaily: Executive Chairman criticises federal approvals pace; Member for Grey lobbies Minister Murray Watt [S15]Political advocacy
17 Apr 2026Federal spokesperson defends rigorous laws and points to 2025 EPBC reforms [S15]Signals no special treatment
4 May 2026March quarterly: cash ~A$90k (per FilingReader); EIS submission planned for May [S13], [S17]Liquidity trough
May 2026Australian Industry Participation plan summary for NRUP approved [S28]Project administrative progress
Q4 FY2026Response to DCCEEW EIS guidelines lodged [S10]Key regulatory milestone
Q4 FY2026Reliance and consultants inspect plant; Reliance begins site preparation in India [S10]Deal execution
8 Jul 2026Last indicative price A$0.001 [S29]Equity near-zero valuation
31 Jul 2026June quarterly: operating cash inflow A$2.259M; A$3.5M+ invoiced for next quarter; EY auditing FY2025 [S10]Liquidity improved; suspension continues
Q1 FY2027Plant dismantling, containerisation and shipment to India expected [S10]Cash milestones

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Results by Segment: Segment operating income NRUP Development rose from AUD -12.5 Mn in FY2022 to AUD -2.8 Mn in FY2024.
NeuRizer Ltd. — Results by Segment
Series (AUD Mn)FY2022FY2023FY2024
Segment operating income NRUP Development-12.5-12.6-2.8
Segment pre-tax income NRUP Development-20.4-16.3-5.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. S1ASX Compliance, "NeuRizer Ltd (ASX: NRZ) – Continuation of Suspension from Quotation", 29 Oct 2024 (aspecthuntley.com.au)
  2. S2NRZ ASX announcement, "Leigh Creek Energy is now known as NeuRizer", 25 Mar 2022 (announcements.asx.com.au)
  3. S3NeuRizer Interim Financial Report, 31 Dec 2022 (asx.com.au)
  4. S4NeuRizer Interim Financial Report, 31 Dec 2023 (announcements.asx.com.au)
  5. S5NRZ ASX, "Managing Director Position Update", 15 Jan 2024 (announcements.asx.com.au)
  6. S6NRZ ASX, "Financial Update" (generator sale-leaseback), 2 Apr 2024 (announcements.asx.com.au)
  7. S7NRZ ASX, "Update on Financial Position" (DL E&C), 5 Feb 2024 (announcements.asx.com.au)
  8. S8NRZ ASX, "Successful Completion of the Entitlement Offer", 24 Nov 2023 (announcements.asx.com.au)
  9. S9NeuRizer Annual Report FY2024 (announcements.asx.com.au)
  10. S10NRZ Quarterly Activities Report and Appendix 5B, Apr–Jun 2026, 31 Jul 2026 (investorpa.com)
  11. S11NRZ ASX, "Important Milestones at Leigh Creek", 13 Mar 2026 (investorpa.com)
  12. S12NRZ ASX, "Chairman's Letter to Shareholders", 13 Mar 2026 (investorpa.com)
  13. S13NRZ Quarterly Report, Mar 2026 quarter, 4 May 2026 (investorpa.com)
  14. S14NRZ Q1 and Q2 FY2026 Quarterly Reports, 31 Mar 2026 — and: investorpa.com · investorpa.com
  15. S15InDaily SA, "SA company makes Hail Mary sale to untangle fertiliser project from red tape", 17 Apr 2026 (indailysa.com.au)
  16. S16Kalkine Media, NeuRizer June 2026 quarter report coverage, 31 Jul 2026 (kalkinemedia.com)
  17. S17FilingReader, "NeuRizer secures India licensing deal amid ASX trading suspension", 4 May 2026 (filingreader.com)
  18. S18TipRanks, NRZ income statement and cash flow — and: tipranks.com · tipranks.com
  19. S19InvestSMART, NRZ financials (investsmart.com.au)
  20. S20Market Index, NRZ (marketindex.com.au)
  21. S21ioCharts, NRZ.AU (preview.iocharts.io)
  22. S22StockLight, NRZ annual reports and announcements index (stocklight.com)
  23. S23SmallCaps, "NeuRizer rebranding breathes new life into proposed SA urea project", Mar 2022 (smallcaps.com.au)
  24. S24Fertilizer Daily / Stamicarbon, "NeuRizer Urea Project relies on Stamicarbon technologies", May 2022 (fertilizerdaily.com)
  25. S25Stock Journal, "SA urea production expected by early 2025", 2022 (stockjournal.com.au)
  26. S26Grain Central, "NeuRizer Urea Project faces ongoing delays" (graincentral.com)
  27. S27Business News Today, NeuRizer–Reliance analysis, 2026 (business-news-today.com)
  28. S28Australian Industry Participation Plan Summary, NRUP, May 2026 (industry.gov.au)
  29. S29InvestSMART, NRZ share price and announcements (investsmart.com.au)
  30. S30NRZ ASX, "Results of Annual General Meeting", 10 Nov 2023 (announcements.asx.com.au)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.